FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Rising Recall

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manuf…

Rising Pharma Holding, Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
Jul 29, 2026
Recall ID
D-0724-2026
Check your lot numberHow we source this data

Summary

Rising Pharma Holding recalled Rising starting Jul 13, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0724-2026 on Jul 29, 2026. Reason: Presence of Precipitate: medication was crystallizing and particles floating in the bottle. Status: Ongoing.

Why it was recalled

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

Product description

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

Lot numbers, UPCs & expiration codes

Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.

Where it was sold

Nationwide U.S.A.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0724-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jul 13, 2026
FDA report date
Jul 29, 2026
Quantity
74208 units
Recall type
Voluntary: Firm initiated
Recalling firm
Rising Pharma Holding, Inc.

Original FDA data

Every field from FDA enforcement report D-0724-2026, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Ongoing
Country
United States
Event ID
99401
Address
2 Tower Center Blvd Ste 1401
Code information
Lots: Batch # CR2518, Exp. 11/2027; Batch # CR2601, Exp. 12/2027; CR2602, CR2603, Exp. 01/2028; CR2604, CR2605, Exp. 02/2028.
Postal code
08816-1149
Report date
Jul 29, 2026
Product type
Drugs
Recall number
D-0724-2026
Classification
Class II
Recalling firm
Rising Pharma Holding, Inc.
Product quantity
74208 units
Reason for recall
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Distribution pattern
Nationwide U.S.A.
Recall initiation date
Jul 13, 2026
Initial firm notification
Letter
Center classification date
Jul 23, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0724-2026, published Jul 29, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls